We’d love to hear your feedback on this activity. It helps us to continually improve our products.
University of Toronto, Toronto, Canada
Prof. Gideon Hirschfield is the Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the Toronto Centre for Liver Disease. He directs the Autoimmune Liver Disease team at the University Health Network and is the clinic director of the Francis Family Liver Clinic. read more
Prof. Hirschfield is a full Professor at the University of Toronto, and was previously a full Professor at the University of Birmingham in the UK. He did his undergraduate training at Oxford and Cambridge Universities, and his PhD was awarded by the University of London.
Prof. Hirschfield is a physician scientist with a focus on autoimmune and rare liver diseases. His clinical work aligns with his academic programme and is exclusive to people living with primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, as well as a variety of rare liver diseases, pre- and post-liver transplant. Aligned with this clinical work, Prof. Hirschfield is involved in a range of translational research/trial programmes focused on improving patient quality and duration of life, as well as in training national and international clinical fellows in autoimmune liver disease care.
Prof. Gideon Hirschfield discloses: Consultancy fees from Advanz Pharma, CymaBay, Dr. Falk Pharma, Escient Pharmaceuticals, Gilead, GSK, Intercept, Ipsen, Mirum and Pliant Therapeutics.
University of Münster, Münster, Germany
Prof. Sonja Ständer is a professor of dermatology and neurodermatology at the University of Münster and the head of the Interdisciplinary Center for Chronic Pruritus (KCP) at the University Hospital Münster in Germany. read more
In 2001, she received her board certification in dermatology, allergology and phlebology. In 2006, she became board certified in dermatopathology after training in Münster and at the Ackermann Academy in New York, USA. In 2008, she established the Center for Chronic Pruritus at the University Hospital Münster and has been the head of this interdisciplinary centre since then. In addition, she played a leading role in the foundation of the first international and national societies for itch. She chairs the European Academy of Dermatology and Venereology Pruritus Task Force, is an author of national and European guidelines for chronic pruritus and chairs psychometric committees (special interest group of the International Forum for the Study of Itch and the itch group of the International Dermatology Outcome Measures).
In 2011, Prof. Ständer obtained the title of professor of dermatology (W3) from the University of Münster and dedicated herself to translational neurodermatology and pruritus research, becoming the worldwide leader in this field. In 2015, Prof. Ständer was awarded a Doctor Honoris Causa title for her research efforts from the University of Wrocław in Poland.
Prof. Sonja Ständer discloses: Advisory board or panel fees from AbbVie, Galderma, Lilly, Pfizer and Sanofi. Consultancy fees from AbbVie, Clexio, Galderma, Incyte, Lilly, Pfizer and Sanofi. Grants/research support from German Research Foundation, Novartis, Sanofi and Trevi Therapeutics. Speaker’s bureau fees from AbbVie, BMS, Eli Lilly, Galderma, Novartis, Pfizer, Sanofi and UCB.
St James’ University Hospital, Leeds, UK
Michelle Clayton is a Liver Nurse Educator at St James’ University Hospital in Leeds and, until recently, was involved in nurse education at the University of Leeds, UK. Michelle has over 30 years of experience in the field of hepatology and liver transplantation. read more
Ms Clayton is passionate about championing quality care for people with liver disease. In April 2019, she became the first elected chairperson for the British Liver Nurses’ Association (BLNA), serving the liver nurse community in the UK. She was also the first chair of the European Association for the Study of the Liver Nurses and Allied Health Professionals taskforce, raising the profile of liver nursing across Europe, until June 2021. Michelle is on the editorial board of Gastrointestinal Nursing and was integral in developing the journal’s Liver Nursing supplement.
Ms Clayton has a large portfolio of publications and speaks both nationally and internationally on a range of care considerations for people with liver disease and liver transplantation. In 2012, she won the Gastrointestinal Nursing Educationist of the Year award for her work in advancing liver nurse education and care, and in 2013 she led and successfully launched the ‘Caring for People with Liver Disease: A Competence Framework for Nursing’. On behalf of the Royal College of Nursing, Ms Clayton worked with the BLNA and British Liver Transplant Group to produce a new competence framework, launched in September 2019, to include caring for people following liver transplantation .
Ms Michelle Clayton discloses: Advisory board or panel fees from Norgine. Other financial or material support (royalties, patent, etc.) from Dr. Falk Pharma.
PBC Foundation, Edinburgh, UK
Collette Thain was diagnosed with primary biliary cholangitis (PBC) in 1994 at the age of 37, having suffered from symptoms since she was 17 years old. read more
Her diagnosis came as a huge shock to the young mother, who was told her disease was incurable and progressive, and the only hope was a liver transplant. Worse to come was the realization that there was no information readily available (not even a leaflet), nor support of any kind, which added to Collette’s feelings of fear and isolation.
Collette, with the help of her hepatologist, managed to obtain help and support from the seven PBC specialist centres within the UK. Through fundraising efforts, support from family and friends and a huge amount of hard work, Collette founded the PBC Foundation in 1996 with the aim of supplying much needed and valuable information to people with PBC wherever it was needed.
Thirty years later, the PBC Foundation is the biggest organization of its kind in the world providing help, support and information to people with PBC and their families in more than 80 countries.
Mrs Collette Thain has no interests/relationships or affiliations to disclose in relation to this activity.